TAK-593
- Generic Name
- TAK-593
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C23H23N7O3
- CAS Number
- 1005780-62-0
- Unique Ingredient Identifier
- H3I42X8XX7
- Background
TAK-593 has been used in trials studying the treatment of Solid Tumors.
- Associated Conditions
- -
- Associated Therapies
- -
Safety Study of TAK-593 Given Orally in Subjects With Nonhematologic Advanced Cancer
- First Posted Date
- 2008-10-16
- Last Posted Date
- 2010-04-27
- Lead Sponsor
- Millennium Pharmaceuticals, Inc.
- Target Recruit Count
- 60
- Registration Number
- NCT00773929
- Locations
- 🇺🇸
Karmanos Cancer Institute, Detroit, Michigan, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath